Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases

FEBS Letters

Volumn 458, Issue 3, 1999, Pages 424-428

  Berchtold, Susanne ^a   Ogilvie, Alexandra L J ^a   Bogdan, Cornelia ^a   Mühl Zürbes, Petra ^a   Ogilvie, Adaling ^a   Schuler, Gerold ^a   Steinkasserer, Alexander ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

ATP; Dendritic cell; Ecto nucleotidase; P2 receptor

Indexed keywords

ADENOSINE TRIPHOSPHATASE; INTERLEUKIN 4; INTERLEUKIN 6; PHOSPHODIESTERASE I; PROSTAGLANDIN E2; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; RECEPTOR SUBTYPE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DENDRITIC CELL; HUMAN; HUMAN CELL; MATURATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

5'-NUCLEOTIDASE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTIGENS, CD; ANTIGENS, SURFACE; CALCIUM; DENDRITIC CELLS; FURA-2; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; RECEPTORS, PURINERGIC P2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032846934     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)01197-7     Document Type: Article

References (29)

1. Banchereau J., Steinman R. Nature. 392:1998;245-252.
2. Schuler G., Steinman R.M. J. Exp. Med. 186:1997;1183-1187.
3. Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., Schuler G. J. Exp. Med. 180:1994;83-93.
4. Sallusto F., Lanzavecchia A. J. Exp. Med. 179:1994;1109-1118.
5. Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., Niederwieser D., Schuler G. J. Immunol. Methods. 196:1996;137-151.
6. Jonuleit H., Kühn U., Müller G., Steinbrink K., Paragnik L., Schmitt E., Knop J., Enk A.H. Eur. J. Immunol. 27:1997;3135-3142.
7. Padeh S., Cohen A., Roifman C.M. J. Immunol. 146:1991;1626-1632.
8. Baricordi O.R., Ferrari D., Melchiorri L., Chiozzi P., Hanau S., Chiari E., Rubini M., Di Virgilio F. Blood. 87:1996;682-690.
9. Falzoni S., Munerati M., Ferrari D., Spisani S., Moretti S., Di Virgilio F. J. Clin. Invest. 95:1995;1207-1216.
10. Gordon J.L. Biochem. J. 233:1986;309-319.
11. Dubyak G.R., El-Moatassim C. Am. J. Physiol. 265:1993;C577-C606.
12. Fredholm B.B. Pharmacol. Rev. 46:1994;143-156.
13. Burnstock G. Neuropharmacology. 36:1997;1127-1139.
14. Burnstock G., King B.F. Drug Dev. Res. 38:1996;67-71.
15. Harden T.K., Boyer J.L., Nicholas R.A. Annu. Rev. Pharmacol. Toxicol. 35:1995;541-579.
16. Komszynski M., Wojtczak A. Biochim. Biophys. Acta. 1310:1996;233-241.
17. Plesner L. Int. Res. Cytol. 158:1995;141-214.
18. Zimmermann H. Biochem. J. 285:1992;345-365.
19. Wang T., Guidotti G. J. Biol. Chem. 271:1996;9898-9901.
20. Wolff K. Arch. Klin. Exp. Dermatol. 218:1964;254-273.
21. Wolff K., Winkelmann R.K. J. Invest. Dermatol. 48:1967;50-54.
22. Girolomoni G., Santantonio M.L., Pastore S., Bergstresser P.R., Giannetti A., Cruz P.D. Jr. J. Invest. Dermatol. 100:1993;282-287.
23. Liu Q.H., Bohlen H., Titzer S., Christensen O., Diehl V., Hescheler J., Fleischmann B.K. FEBS Lett. 445:1999;402-408.
24. Le K.T., Paquet M., Nouel D., Babinski K., Seguela P. FEBS Lett. 418:1997;195-199.
25. Clifford E.E., Martin K.A., Dalal P., Thomas R., Dubyak G.R. Am. J. Physiol. 273:1997;C973-C987.
26. Jin J., Dasari V.R., Sistare F.D., Kunapuli S.P. Br. J. Pharmacol. 123:1998;789-794.
27. Treves S., Di Virgilio F., Cerundolo V., Zanovello P., Collavo D., Pozzan T. J. Exp. Med. 166:1987;33-42.
28. Ogilvie A., Lüthje J., Pohl U., Busse R. Biochem. J. 259:1989;97-103.
29. Di Virgilio F. Immunol. Today. 16:1995;524-528.